Shelter Pharma Fund Raise of ₹25.31 Cr

Shelter Pharma Other Announcement

Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.

Shelter Pharma H1 FY27 Results: Net Profit ₹5.2 Cr, Up 15.6% YoY

Shelter Pharma Ltd reported revenue from operations of ₹45.1 Cr (+35.4% YoY) and net profit of ₹5.2 Cr (+15.6% YoY) for H1 FY27.

Key figure

Net profit ₹5.2 Cr · +15.6% YoY

Shelter Pharma Board Meeting Date

Shelter Pharma intimated its Board meeting is scheduled for November 7, 2026, to approve H1 FY27 unaudited results. Trading window remains closed until November 9, 2026.

Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C

Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.

Value

₹0.22 Cr

From

First Vet Veterinary Medicines Trading L.L.C

Execution

Within the mutually agreed timelines as per the purchase order schedule

Shelter Pharma Bags ₹0.1 Cr Order from Genet International

Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.

Value

₹0.10 Cr

From

Genet International

Execution

Within mutually agreed timelines as per the purchase order schedule

Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.

Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.

Value

₹3.15 Cr

From

Taha Drugs & Chemicals Co. Ltd.

Execution

Within mutually agreed timelines as per purchase order schedule

Om Metallogic Fund Raise

Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.

Virinchi Fund Raise of ₹30 Cr

Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.

Value

₹30.00 Cr

Execution

Warrant tenure not exceeding 18 months from allotment

IIFL Finance Fund Raise of ₹6,414 Cr

IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.

Value

₹6,414 Cr

Bajaj Finance Fund Raise of ₹5,800 Cr

Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.

Value

₹5,800 Cr

Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr

Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.

Value

₹5,000 Cr

Execution

Allotment to be completed within 365 days of shareholder approval

HB Leasing & Finance Co Fund Raise

HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.